Welcome to our dedicated page for Claritev SEC filings (Ticker: CTEV), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Claritev's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Claritev's regulatory disclosures and financial reporting.
Claritev Corporation (CTEV) reported that its Board of Directors appointed Ben Letham as a Class I director and member of the Board’s Risk Committee, effective September 14, 2026, filling the vacancy created by the passing of John Prince.
Letham is an AI and optimization specialist who currently serves as a research scientist at Meta and co-created the open-source forecasting tool Prophet. Claritev states that he has no family relationships with directors or executives and no material related-party interests, and that he will be compensated under the existing non-employee director compensation policy and enter into the standard indemnification agreement. Claritev furnished a press release announcing his appointment as a Regulation FD disclosure.
Claritev Corp (CTEV) reported that director and Pres., CEO & Executive Chair Dalton Travis had two indirect open-market purchases of Class A common stock through his spouse's Individual Retirement Account. On 2026-08-27, 4,500 shares were purchased at a weighted average price of $38.8052 per share, in multiple trades between $38.29 and $39.00. On 2026-08-28, 1,950 shares were purchased at a weighted average price of $38.4823 per share, in multiple trades between $38.36 and $38.50. A separate line reports 498,353 shares of Class A common stock held directly after the reported transactions.
Claritev Corp (CTEV) reported that officer Tiffani Misencik, SVP and Chief Growth Officer, sold 8,850 shares of Class A common stock on 2026-08-14 in an open market or private transaction. The weighted average sale price was $40.067 per share, and Misencik now holds 123,723 shares directly.
The sale price reflects multiple trades executed within a range of $38.05 to $41.72 per share.
Claritev Corp senior vice president and chief strategy officer William B. Mintz reported selling 8,431 shares of Class A common stock on 2026-08-10 at $34.24 per share in an open market or private transaction. Following this sale, he directly holds 71,195 shares of Claritev Corp common stock.
Claritev Corp reported that SVP and Chief Strategy Officer William B. Mintz had 3,622 shares of Class A common stock withheld on August 5, 2026 to pay tax liability arising from the vesting of restricted stock units, at $26.13 per share. After this tax-withholding disposition, Mintz directly holds 79,626 shares.
Claritev Corp EVP & CFO Garis Douglas Michael had 11,711 shares of Class A common stock withheld on August 5, 2026 at $26.13 per share to pay taxes on vesting restricted stock units. He now holds 194,441 shares directly, plus additional indirect holdings in several family Individual Retirement Accounts.
Claritev Corporation, a healthcare technology and data company, reported Q2 2026 revenue of $257,478 thousand, up 6.6% year over year, driven by 13.7% growth in Claims Intelligence Solutions. Network Solutions and Payment & Revenue Integrity declined modestly. Operating income rose to $23,409 thousand, but interest expense of $100,253 thousand led to a net loss of $59,226 thousand (loss per share $3.49). EBITDA was $134,113 thousand and Adjusted EBITDA $155,799 thousand; Adjusted EPS was $1.41.
As of June 30, 2026, Claritev held $27.7 million in cash and restricted cash and carried gross long-term debt of $4,637,003 thousand, resulting in a total shareholders’ deficit of $287,839 thousand. The company had $70.0 million drawn and $273.6 million available under its $350.0 million revolving credit facility. Operating cash flow for the first half was $46,892 thousand, partly funding $84,847 thousand of capital expenditures tied to its Vision 2030 transformation program.
Claritev disclosed ongoing multidistrict antitrust litigation and a civil Department of Justice inquiry, while noting the DOJ closed a related antitrust grand jury proceeding and confirmed it was not pursuing a criminal investigation. One client represented 35.0% of Q2 revenue. Management reported a continuing material weakness in IT general controls, leaving disclosure controls not effective while remediation efforts continue.
Claritev Corporation reported second quarter 2026 results with revenues of $257.5 million, up 6.6% from $241.6 million in Q2 2025. Net loss was $59.2 million versus $62.6 million a year earlier, while Adjusted EBITDA rose 1.1% to $155.8 million, for a 60.5% margin compared with 63.8%.
The company generated strong cash metrics, with net cash from operating activities of $92.7 million versus $61.2 million and free cash flow of $54.6 million versus $36.6 million. Management highlighted more than $70 million in bookings in the first half of 2026 toward a $100 million full-year target.
Claritev raised its full-year 2026 outlook, guiding revenues to $1.00–$1.02 billion (from $985 million–$1.0 billion) and Adjusted EBITDA to $610–$620 million (from $605 million–$615 million), and increased free cash flow guidance to $5–$15 million. As of June 30, 2026, long-term debt was $4,588,160 (in thousands) and total shareholders’ deficit was $287,839 (in thousands).